The pharmaceutical and biological sector has been heavily sold off by the main funds in the past three days
In shenwanyi industry, the concept of the largest net outflow of main funds in recent 3 days is the pharmaceutical and biological sector, among which the top stocks of the net outflow of main funds are Jiu'An medical, Watson biology and * ST Kangmei, with a net outflow of 836 million yuan, 697 million yuan and 651 million yuan respectively; The stocks with the largest net inflow were kailaiying, Jincheng pharmaceutical and tiger pharmaceutical, with net inflows of RMB 333 million, RMB 320 million and RMB 158 million respectively.
In-depth
Briefing Jun 13, 2022 09:44 AM
· Healthcare
Cro plate fell, and Wuxi apptec fell nearly 10%
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Briefing Feb 21, 2022 10:29 AM
· Healthcare
Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team
In-depth
Healthcare
WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell
According to the latest quarterly index review, a Wuxi-based CRO company will be incorporated into the FTSE China A 50 Share Index. It has been considered a top holding by many MSCI China indexes for some time.
Jun 08, 2020 09:51 AM
See more
Read next
Insight
In-depth
Insight
In-depth